Mary Madison, RN, RAC-CT, CDP
Clinical Consultant – Briggs Healthcare
On February 10, 2021, CDC updated Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States.
All the updates are significant and should be reviewed. I want to point out the 4th bullet that updates quarantine recommendations for fully vaccinated persons as well as the additional considerations for individuals in healthcare settings.
However, vaccinated persons with an exposure to someone with suspected or confirmed COVID-19 are not required to quarantine if they meet all of the following criteria:
- Are fully vaccinated (i.e., ≥2 weeks following receipt of the second dose in a 2-dose series, or ≥2 weeks following receipt of one dose of a single-dose vaccine)
- Are within 3 months following receipt of the last dose in the series
- Have remained asymptomatic since the current COVID-19 exposure
Persons who do not meet all 3 of the above criteria should continue to follow current quarantine guidance after exposure to someone with suspected or confirmed COVID-19.
Also updated on February 19, 2021 is Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic.
Updated February 9, 2021 is Healthcare Professional Preparedness Checklist for Transport and Arrival of Patients with Confirmed or Possible COVID-19. On this webpage, you’ll find the Healthcare Professional Preparedness Checklist as well as many other educational resources.
Strategies for Optimizing the Supply of N95 Respirators was updated February 10, 2021.